Schedule 13G ownership disclosure

EDESA BIOTECH INC

Common Stock · CUSIP: 27966L306

Event date: 2025-02-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Stonepine Capital Management, LLC

    Shares: 693,551.00 · Class: 9.9%

  • Stonepine Capital, L.P.

    Shares: 693,551.00 · Class: 9.9%

  • Stonepine GP, LLC

    Shares: 693,551.00 · Class: 9.9%

  • Jon M. Plexico

    Shares: 693,551.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000197
Form type
SCHEDULE 13G
Filer
Edesa Biotech, Inc.
CIK
CIK 1540159
Filed
Feb 25, 2025
Reporting period
Feb 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub